tetano
Editor, Senior Moderator
Vaccine
Available online 17 August 2012
In Press, Uncorrected Proof ? Note to users
Cover image
Conference report
Summary for Symposium I on the Development of a More Efficacious Influenza Vaccine Held at the 15th Annual Meeting of the Japanese Society for Vaccinology, Tokyo, 2011
Takuji KumagaiCorresponding author contact information, E-mail the corresponding author
Kohjinkai Health Care, Kumagai Pediatric Clinic, West 6, Momijidai, Atsubetsu-Ku, Sapporo 004-0013, Japan
Hiroshi Kiyono
Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
Accepted 17 July 2012. Available online 17 August 2012.
http://dx.doi.org/10.1016/j.vaccine.2012.07.091, How to Cite or Link Using DOI
Influenza HA split vaccine is widely administered to children and adults worldwide. However, its limited efficacy and weak potential to control the next influenza pandemic has recently been emphasized and has raised serious concerns. These circumstances led the Japanese Society for Vaccinology to organize this symposium to discuss the next generation of influenza vaccine which should be more efficacious and much safer. The symposium covered data assessment of the newly developed H5N1 vaccine, adjuvant development for influenza vaccine, the future threat of H5N1 influenza, measures for its control, and the recent development of a mucosal vaccine.
http://www.sciencedirect.com/science/article/pii/S0264410X12011772
Available online 17 August 2012
In Press, Uncorrected Proof ? Note to users
Cover image
Conference report
Summary for Symposium I on the Development of a More Efficacious Influenza Vaccine Held at the 15th Annual Meeting of the Japanese Society for Vaccinology, Tokyo, 2011
Takuji KumagaiCorresponding author contact information, E-mail the corresponding author
Kohjinkai Health Care, Kumagai Pediatric Clinic, West 6, Momijidai, Atsubetsu-Ku, Sapporo 004-0013, Japan
Hiroshi Kiyono
Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
Accepted 17 July 2012. Available online 17 August 2012.
http://dx.doi.org/10.1016/j.vaccine.2012.07.091, How to Cite or Link Using DOI
Influenza HA split vaccine is widely administered to children and adults worldwide. However, its limited efficacy and weak potential to control the next influenza pandemic has recently been emphasized and has raised serious concerns. These circumstances led the Japanese Society for Vaccinology to organize this symposium to discuss the next generation of influenza vaccine which should be more efficacious and much safer. The symposium covered data assessment of the newly developed H5N1 vaccine, adjuvant development for influenza vaccine, the future threat of H5N1 influenza, measures for its control, and the recent development of a mucosal vaccine.
http://www.sciencedirect.com/science/article/pii/S0264410X12011772